Literature DB >> 26576387

Paying Out of Pocket for Healthcare in Bangladesh - A Burden on Poor?

Nazmul M Huq1, Abul Quasem Al-Amin2, Sushil Ranjan Howlader3, Mohammad Alamgir Kabir1.   

Abstract

Entities:  

Year:  2015        PMID: 26576387      PMCID: PMC4645756     

Source DB:  PubMed          Journal:  Iran J Public Health        ISSN: 2251-6085            Impact factor:   1.429


× No keyword cloud information.

Dear Editor-in-Chief

Out-of-pocket (OOP) expenditures for healthcare continue to be the most significant means of healthcare issue in the developing world and constitute a large share of their living financial plan (1, 2). The healthcare expenditures are largely unpredictable and usually have a negative impact on the poor households, while large expenditures have catastrophic impacts on household welfare. A sudden serious feature of the illness deceits in the critical susceptibility of the poor to an unexpected and unforeseen healthcare related vulnerabilities, increased indebtedness due to income loss, and even employment. Thus, the illness and its related caring expenditures and consequent impacts can severely disrupt living standards (3). A household that has the misfortune to succumb to illness and whose spending pattern is disrupted suffers a further welfare loss (2). The magnitude of this welfare loss will depend upon the living standards of that particular household. A well-off household can finance medical expenses from savings, or by reducing on luxury stuffs of consumption. However, a less well-off household is bound to cut back on daily necessities and could be placed into further shortage for living budgets (1). Impulsive healthcare expenditures can expose households to a considerable financial risk, while many forego such expenses thereby raising the level and extent of morbidity. Out-of-pocket healthcare expenditures of households in Bangladesh comprise 64.3% share of the total health expenditure and collectively spent approximately Taka 103.46 billion (US$1.49 billion) in yearly on health (4). High OOP expenditure in purchasing pharmaceuticals is the most distinctive feature in Bangladesh. Nearly 62% of the healthcare expenditure is on purchasing drugs and medical consultations (3). The high proportion of expenditure on drug reflects a high level of self-treatment and self-medication and in terms of share of household medical expenditure is diagnostic and imaging, which is about 10.6% (3). Households also spend a significant portion of its income on transportation is about 6.2% related to healthcare services and facilities (i.e. ambulance/car rental). It is observed that a household, on an average, spends 7.5% of its total income for and the poorest 20% spent approximately 13.5% of their income for purchasing health care (3). Thus, the intensity of catastrophic payments for various threshold levels reveals that approximately 29.2% of the households spend more than 5% of their total resources for health care. Hence, the OOP expenditures for health care services have been sufficiently costly in Bangladesh. The OOP healthcare expenditure sufficiently expensive as 25.5% of the population in Bangladesh is below poverty line (5). Healthcare expenditures add another 4.2% population yearly (5.8 million people) to the extreme poverty. In absolute terms, the poverty impact of OOP expenditures for health care is substantially worse where the rates of poverty are higher and OOP health care expenditures have the most devastating impact and causes considerable financial risk. If this burden can be relieved by pointing and provisioning of public healthcare system, this would substantially mitigate the effects on poor households and poverty. Further, normalized gap measures suggest that additional healthcare expenditures incurred by poor households not only raise the poverty prevalence, but also increase the poverty intensity over time (1, 2). This strongly provides the evidence that low health facilities and status of the population is a major factor for the persistence of poverty and it can be relieved by proper targeting and provisioning of public healthcare. How to reduce the OOP expenditures and decrease the share of household living standards is a fundamental question (6, 7). Therefore, it is a significant subject to identify the linkage between health, healthcare provision and poverty in Bangladesh. Recently, one basis, which is used for assessing the performance of health systems, is through the determination of the extent to which households are protected from unforeseen OOP expenditures and poverty induced effects of expenditures for such health care. Appropriate attention has hardly been given in Bangladesh to recognize the linkage between health, healthcare provision and poverty, which could be the basis for the public investment policies on the condition of health and living standard. It is evident that the poor are worse protected from healthcare burdens in Bangladesh. Therefore, the national policies should emphasize the poverty reduction strategies through improved healthcare status of the individuals. This also calls for investment in the health sector as a continuing process, especially in the rural areas, and then the outcomes contribute to sustainable development.
  3 in total

1.  Effect of payments for health care on poverty estimates in 11 countries in Asia: an analysis of household survey data.

Authors:  Eddy van Doorslaer; Owen O'Donnell; Ravi P Rannan-Eliya; Aparnaa Somanathan; Shiva Raj Adhikari; Charu C Garg; Deni Harbianto; Alejandro N Herrin; Mohammed Nazmul Huq; Shamsia Ibragimova; Anup Karan; Chiu Wan Ng; Badri Raj Pande; Rachel Racelis; Sihai Tao; Keith Tin; Kanjana Tisayaticom; Laksono Trisnantoro; Chitpranee Vasavid; Yuxin Zhao
Journal:  Lancet       Date:  2006-10-14       Impact factor: 79.321

2.  Catastrophic payments for health care in Asia.

Authors:  Eddy van Doorslaer; Owen O'Donnell; Ravindra P Rannan-Eliya; Aparnaa Somanathan; Shiva Raj Adhikari; Charu C Garg; Deni Harbianto; Alejandro N Herrin; Mohammed Nazmul Huq; Shamsia Ibragimova; Anup Karan; Tae-Jin Lee; Gabriel M Leung; Jui-Fen Rachel Lu; Chiu Wan Ng; Badri Raj Pande; Rachel Racelis; Sihai Tao; Keith Tin; Kanjana Tisayaticom; Laksono Trisnantoro; Chitpranee Vasavid; Yuxin Zhao
Journal:  Health Econ       Date:  2007-11       Impact factor: 3.046

3.  Coping with health-care costs: implications for the measurement of catastrophic expenditures and poverty.

Authors:  Gabriela Flores; Jaya Krishnakumar; Owen O'Donnell; Eddy van Doorslaer
Journal:  Health Econ       Date:  2008-12       Impact factor: 3.046

  3 in total
  10 in total

Review 1.  Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission.

Authors:  Shiv K Sarin; Manoj Kumar; Mohammed Eslam; Jacob George; Mamun Al Mahtab; Sheikh M Fazle Akbar; Jidong Jia; Qiuju Tian; Rakesh Aggarwal; David H Muljono; Masao Omata; Yoshihiko Ooka; Kwang-Hyub Han; Hye Won Lee; Wasim Jafri; Amna S Butt; Chern H Chong; Seng G Lim; Raoh-Fang Pwu; Ding-Shinn Chen
Journal:  Lancet Gastroenterol Hepatol       Date:  2019-12-15

2.  Assessment of quality of life and its determinants in type-2 diabetes patients using the WHOQOL-BREF instrument in Bangladesh.

Authors:  Mohammod Feroz Amin; Bishwajit Bhowmik; Rozana Rouf; Monami Islam Khan; Syeda Anika Tasnim; Faria Afsana; Rushda Sharmin; Kazi Nazmul Hossain; Md Abdullah Saeed Khan; Samiha Mashiat Amin; Md Shek Sady Khan; Md Faruque Pathan; Mohammad Jahid Hasan
Journal:  BMC Endocr Disord       Date:  2022-06-18       Impact factor: 3.263

3.  Impoverishment impact of out-of-pocket payments for healthcare in rural Bangladesh: Do the regions facing different climate change risks matter?

Authors:  Afroza Begum; Syed Abdul Hamid
Journal:  PLoS One       Date:  2021-06-04       Impact factor: 3.752

4.  Symptom Prevalence in Patients with Advanced, Incurable Illness in Bangladesh.

Authors:  Megan Doherty; Farzana Khan; Fazle Noor Biswas; Marufa Khanom; Rubayat Rahman; Mohammad Munirul Islam Tanvir; Farhana Akter; Mridul Sarker; Nezamuddin Ahmad
Journal:  Indian J Palliat Care       Date:  2017 Oct-Dec

Review 5.  Genetic counseling in the context of Bangladesh: current scenario, challenges, and a framework for genetic service implementation.

Authors:  Mohammad Jakir Hosen; Saeed Anwar; Jarin Taslem Mourosi; Sourav Chakraborty; Md Faruque Miah; Olivier M Vanakker
Journal:  Orphanet J Rare Dis       Date:  2021-04-09       Impact factor: 4.123

6.  Demographic differentials of lung cancer survival in Bangladeshi patients.

Authors:  Muhammad Rafiqul Islam; A T M Kamrul Hasan; Nazrina Khatun; Ishrat Nur Ridi; Md Mamun Or Rasheed; Syed Mohammad Ariful Islam; Md Nazmul Karim
Journal:  PLoS One       Date:  2021-12-10       Impact factor: 3.240

7.  Feasibility and acceptability of telepathology system among the rural communities of Bangladesh: A pilot study.

Authors:  Md Jiaur Rahman; Md Moshiur Rahman; Ryota Matsuyama; Miwako Tsunematsu; Rafiqul Islam; Ashir Ahmed; Bilkis Banu; Sarder Mahmud Hossain; Mohammad Habibur Rahman Sarker; Forhad Monjur; Md Marufur Roshid; Md Rashedul Islam; Masayuki Kakehashi
Journal:  J Family Med Prim Care       Date:  2022-06-30

8.  Profile of stroke patients treated at a rehabilitation centre in Bangladesh.

Authors:  Firoz Ahmed Mamin; Muhammad Shahidul Islam; Farjana Sharmin Rumana; Farhana Faruqui
Journal:  BMC Res Notes       Date:  2017-10-27

9.  Rural community perceptions of antibiotic access and understanding of antimicrobial resistance: qualitative evidence from the Health and Demographic Surveillance System site in Matlab, Bangladesh.

Authors:  Moyukh Chowdhury; Jennifer Stewart Williams; Heiman Wertheim; Wasif Ali Khan; Abdul Matin; John Kinsman
Journal:  Glob Health Action       Date:  2019-12-13       Impact factor: 2.640

10.  Older adults with non-communicable chronic conditions and their health care access amid COVID-19 pandemic in Bangladesh: Findings from a cross-sectional study.

Authors:  Sabuj Kanti Mistry; A R M Mehrab Ali; Uday Narayan Yadav; Saruna Ghimire; Md Belal Hossain; Suvasish Das Shuvo; Manika Saha; Sneha Sarwar; Md Mohibur Hossain Nirob; Varalakshmi Chandra Sekaran; Mark F Harris
Journal:  PLoS One       Date:  2021-07-29       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.